Pomalidomide
Publication type: Journal Article
Publication date: 2013-10-03
scimago Q1
wos Q1
SJR: 5.823
CiteScore: 23.0
Impact factor: 23.1
ISSN: 00064971, 15280020
PubMed ID:
23974193
Biochemistry
Cell Biology
Immunology
Hematology
Abstract
This spotlight review focuses on the second-generation immunomodulatory drug pomalidomide, which was recently approved by the US Food and Drug Administration. This drug was approved for patients with multiple myeloma who have received at least 2 prior therapies, including lenalidomide and bortezomib, and have demonstrated disease progression on or within 60 days of completion of the last therapy. This review focuses on the clinical trial data that led to approval and provides advice for treating physicians who are now prescribing this drug for patients.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
|
|
|
Blood
4 publications, 4.76%
|
|
|
Cancers
3 publications, 3.57%
|
|
|
Pharmaceuticals
3 publications, 3.57%
|
|
|
Expert Review of Hematology
3 publications, 3.57%
|
|
|
Leukemia
2 publications, 2.38%
|
|
|
Bioorganic and Medicinal Chemistry
2 publications, 2.38%
|
|
|
Leukemia and Lymphoma
2 publications, 2.38%
|
|
|
bioRxiv
2 publications, 2.38%
|
|
|
Future Oncology
1 publication, 1.19%
|
|
|
Oncotarget
1 publication, 1.19%
|
|
|
American Journal of Nursing
1 publication, 1.19%
|
|
|
Therapeutic Advances in Infectious Disease
1 publication, 1.19%
|
|
|
Therapeutic Advances in Hematology
1 publication, 1.19%
|
|
|
Frontiers in Medicine
1 publication, 1.19%
|
|
|
Frontiers in Oncology
1 publication, 1.19%
|
|
|
Frontiers in Immunology
1 publication, 1.19%
|
|
|
Pediatric Research
1 publication, 1.19%
|
|
|
Bone Marrow Transplantation
1 publication, 1.19%
|
|
|
Cancer and Metastasis Reviews
1 publication, 1.19%
|
|
|
Cell Chemical Biology
1 publication, 1.19%
|
|
|
Current Hematologic Malignancy Reports
1 publication, 1.19%
|
|
|
Blood Cancer Journal
1 publication, 1.19%
|
|
|
Seminars in Hematology
1 publication, 1.19%
|
|
|
Regenerative Therapy
1 publication, 1.19%
|
|
|
Journal of Infection and Chemotherapy
1 publication, 1.19%
|
|
|
PLoS ONE
1 publication, 1.19%
|
|
|
American Journal of the Medical Sciences
1 publication, 1.19%
|
|
|
Human Pathology: Case Reports
1 publication, 1.19%
|
|
|
Bioorganic Chemistry
1 publication, 1.19%
|
|
|
1
2
3
4
|
Publishers
|
2
4
6
8
10
12
14
16
18
|
|
|
Elsevier
18 publications, 21.43%
|
|
|
Springer Nature
10 publications, 11.9%
|
|
|
Taylor & Francis
9 publications, 10.71%
|
|
|
MDPI
6 publications, 7.14%
|
|
|
Wiley
6 publications, 7.14%
|
|
|
American Chemical Society (ACS)
4 publications, 4.76%
|
|
|
American Society of Hematology
4 publications, 4.76%
|
|
|
Frontiers Media S.A.
3 publications, 3.57%
|
|
|
American Association for Cancer Research (AACR)
3 publications, 3.57%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 2.38%
|
|
|
SAGE
2 publications, 2.38%
|
|
|
Public Library of Science (PLoS)
2 publications, 2.38%
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 2.38%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 2.38%
|
|
|
Impact Journals
1 publication, 1.19%
|
|
|
Japanese Society of Regenerative Medicine
1 publication, 1.19%
|
|
|
Oxford University Press
1 publication, 1.19%
|
|
|
American Society of Health-System Pharmacists
1 publication, 1.19%
|
|
|
BMJ
1 publication, 1.19%
|
|
|
Hindawi Limited
1 publication, 1.19%
|
|
|
American Society of Clinical Oncology (ASCO)
1 publication, 1.19%
|
|
|
The Japan Society for Hematopoietic Stem Cell Transplantation
1 publication, 1.19%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 1.19%
|
|
|
Spandidos Publications
1 publication, 1.19%
|
|
|
2
4
6
8
10
12
14
16
18
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
84
Total citations:
84
Citations from 2025:
12
(14.29%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
RIS
Copy
TY - JOUR
DO - 10.1182/blood-2013-05-484782
UR - https://doi.org/10.1182/blood-2013-05-484782
TI - Pomalidomide
T2 - Blood
AU - Lacy, Martha Q.
AU - Mccurdy, Arleigh R
PY - 2013
DA - 2013/10/03
PB - American Society of Hematology
SP - 2305-2309
IS - 14
VL - 122
PMID - 23974193
SN - 0006-4971
SN - 1528-0020
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2013_Lacy,
author = {Martha Q. Lacy and Arleigh R Mccurdy},
title = {Pomalidomide},
journal = {Blood},
year = {2013},
volume = {122},
publisher = {American Society of Hematology},
month = {oct},
url = {https://doi.org/10.1182/blood-2013-05-484782},
number = {14},
pages = {2305--2309},
doi = {10.1182/blood-2013-05-484782}
}
Cite this
MLA
Copy
Lacy, Martha Q., and Arleigh R Mccurdy. “Pomalidomide.” Blood, vol. 122, no. 14, Oct. 2013, pp. 2305-2309. https://doi.org/10.1182/blood-2013-05-484782.